title: Correspondence regarding: Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome by Bhatt et al.
authors.affiliation: St Vincent's Clinic/UNSW/VCCRI, Darlinghurst, NSW, Australia M.ORourke@unsw.edu.au.
authors.forename: Michael F
authors.initials: MF
authors.lastname: O'Rourke
authors.affiliation: St Vincent's Clinic/UNSW/VCCRI, Darlinghurst, NSW, Australia.
authors.forename: Audrey
authors.initials: A
authors.lastname: Adji
authors.affiliation: Klinikum Wels-Grieskirchen, Wels, Austria.
authors.forename: Thomas
authors.initials: T
authors.lastname: Weber
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001014:Aortic Aneurysm / Q000517:prevention & control*; D001262:Atenolol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy*; D059289:Vascular Stiffness / Q000187:drug effects*
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D001262:Atenolol; D019808:Losartan
keywords: Marfan syndrome; atenolol; augmentation index; losartan